Zhejiang Xianju Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ROCURONIUM BROMIDE USP NON-STERILE BULK DRUG SUBSTANCE, with a corresponding US DMF Number 26765.
Remarkably, this DMF maintains an Active status since its submission on December 27, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 03, 2024, and payment made on January 25, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II